17 results on '"Lorey S"'
Search Results
2. A common functional consequence of tumor-derived mutations within c-MYC
3. Constitutive expression of Interleukin-18 and Interleukin-18 receptor mRNA in tumour derived human B-cell lines
4. Interaction of MYC with host cell factor-1 is mediated by the evolutionarily conserved Myc box IV motif
5. A common functional consequence of tumor-derived mutations within c-MYC
6. Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)
7. Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor.
8. Steroid Alkaloid Glycosides from Solanum Coccineum
9. Ubiquitin is a versatile scaffold protein for the generation of molecules with de novo binding and advantageous drug-like properties.
10. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC.
11. Novel ubiquitin-derived high affinity binding proteins with tumor targeting properties.
12. Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire.
13. Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites.
14. Transcellular proteolysis demonstrated by novel cell surface-associated substrates of dipeptidyl peptidase IV (CD26).
15. Autocrine role of macrophage inflammatory protein-1 beta in human T-cell lymphotropic virus type-I tax-transfected Jurkat T-cells.
16. A new type of fluorogenic substrates for determination of cellular dipeptidyl peptidase IV (DP IV/CD26) activity.
17. New fluorogenic dipeptidyl peptidase IV/CD26 substrates and inhibitors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.